Falcon Opportunity Partners, LLC provides capital to companies with significant growth prospects, compelling strategic positions and clear paths to profitability. We seek opportunities to partner with excellent management teams and entrepreneurs who are passionate about their business and committed to value creation.

Synogen partners with select early-stage biotech and med-tech companies, providing seed-stage financing as well as assistance in regulatory affairs, intellectual property issues, strategic planning, financial forecasting, market research and management. With more than 20 associates who are experts in their fields, they bring many years of experience and success in medical technology development and commercialization. Synogen's focus is on bringing technologies to market rapidly, gaining regulatory approval quickly, and producing profitable operations at the earliest stage possible in company development.




Emergent Growth Fund, LLC (Emergent) is a member-managed angel investment group, focusing on early stage companies developing unique, leading-edge products, or proprietary technologies that possess the potential for rapid growth in significant markets. Its members are actively involved in the venture capital process, and its strength lies in its members - highly successful businesspeople and investors with extensive experience in building companies and selecting investments.

Emergent is fully funded by its members and makes direct investments in its portfolio companies. It helps its portfolio companies be successful and profitable by leveraging the diverse expertise of its members.